Why Autolus Therapeutics (AUTL) Looks Less Speculative as AUCATZYL Revenue Builds

3 days ago 5

Habib Ur Rehman

Wed, June 17, 2026 astatine 10:16 AM CDT 2 min read

Autolus Therapeutics plc (NASDAQ:AUTL) is 1 of the small-cap stocks with imaginable to emergence 1000 percent. Unlike galore biotech companies that are inactive waiting for their archetypal approved product, Autolus already has a attraction connected the market. Its cause AUCATZYL, besides known arsenic obe-cel, is approved for adults with a hard-to-treat signifier of humor crab called relapsed oregon refractory B-cell acute lymphoblastic leukemia. In its May 14 first-quarter update, Autolus reported $26.2 cardinal successful AUCATZYL nett merchandise revenue, up from $9.0 cardinal a twelvemonth earlier, and said the concern reached affirmative gross borderline for the archetypal time.

Autolus besides kept its 2026 AUCATZYL gross guidance astatine $120 cardinal to $135 million, compared with $74 cardinal successful 2025. The institution is trying to grow obe-cel beyond its archetypal approved use, with studies successful pediatric ALL, lupus nephritis, and progressive aggregate sclerosis. On May 21, Autolus said an ASCO abstract from the FELIX survey showed a 59% wide remission complaint and a 42.6-month median duration of effect successful patients whose crab had dispersed extracurricular the bony marrow, a difficult-to-treat subgroup. Autolus ended the archetypal 4th with $229.4 cardinal successful cash, currency equivalents, and marketable securities, capable to money operations into the 4th fourth of 2027.

Why Autolus Therapeutics (AUTL) Looks Less Speculative arsenic AUCATZYL Revenue Builds

Autolus Therapeutics plc (NASDAQ:AUTL) is simply a commercial-stage biopharmaceutical institution processing programmed T-cell therapies for crab and autoimmune diseases.

While we admit the imaginable of AUTL arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article